Semantic Scholar uses AI to extract papers important to this topic.
Activities of noncompetitive NMDA receptor antagonists (aminoadamantane derivatives) were assessed in random-bred rats with… Expand Activity of hemantane, an amino adamantane derivative, exhibiting the properties of lowaffinity non-competitive NMDA receptor… Expand The efficacy of some aminoadamantane derivatives used as neurodegeneration treatments is due
to their ability to block NMDA… Expand s | 67 symptoms gradually decreased. Subsequently, we resumed HBO. Combination therapy of TRH and HBO dramatically improved to… Expand Hemantane demonstrated a pronounced antiparkinsonian activity in the model of hemiparkinsonian syndrome provoked in rats by… Expand Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg… Expand A large body of literature supports the idea that inflammation exacerbates neurodegenerative pathology. This idea is also… Expand Chronic administration of levodopa and benserazide (10 and 15 mg/kg, respectively) cause the development of dyskinesia in rats… Expand The effect of Hemantane, a new 2-aminoadamantane derivative (N-adamant-2-ylhexamethylenimine hydrochloride) with antiparkinsonian… Expand N-(Adamant-2-yl)hexamethyleneimine hydrochloride (hemantane) is a new potential antiparkinsonian drug with a complex mechanism of… Expand